Naltrexone (depot)

DRUG2 trials

Sponsors

University of Arkansas, BioCorRx Pharmaceuticals Inc

Conditions

Drug DependenceHealthy Adult Male and Female Volunteers

Phase 1

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

Not yet recruitingNCT07269873

BioCorRx Pharmaceuticals IncHealthy Adult Male and Female Volunteers

Start: 2026-01-13End: 2026-12-05Target: 30Updated: 2025-12-08

Phase 2

Improving Treatment Outcomes for Prescription Opioid Dependence

CompletedNCT02543944

University of ArkansasDrug Dependence

Start: 2016-02-29End: 2021-05-31Updated: 2022-07-28

Related Papers

Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone.

2025-12-16